Skip to content
Stop using now Medical device recall · FDA · Published April 27, 2021

Circulatory Technology Better-Bladder BB14: Risk of Circuit Collapse During ECMO Use

Circulatory Technology recalls The Better-Bladder BB14 ECMO circuit component due to potential collapse during use, which may cause reduced blood flow. Affected units have specific model and lot numbers.

🇺🇸 FDA recall #Z-1862-2021Medical deviceCirculatory Technology ›
Take action

Contact the company

Recalling firmCirculatory Technology Inc.21 Singworth St · Oyster Bay, NY 11771-3703
✎ GovInfoNow plain-language explainer

What happened, in plain English

Circulatory Technology recalls The Better-Bladder BB1:4 ECMO circuit component because it may collapse during use, causing reduced blood flow. This is a serious risk for patients using ECMO life support systems. Read more at govinfonow.com/recall/62696-circulatory-technology-better-bladder-bb14-risk-of-circuit-collapse-during.

Source Summary by GovInfoNow · govinfonow.com/recall/62696-circulatory-technology-better-bladder-bb14-risk-of-circuit-collapse-during · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1862-2021

Cite this page

“Circulatory Technology Better-Bladder BB14: Risk of Circuit Collapse During ECMO Use.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62696-circulatory-technology-better-bladder-bb14-risk-of-circuit-collapse-during. Based on FDA recall #Z-1862-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1862-2021%22&limit=1).

Why it’s dangerous

The Better-Bladder may collapse during ECMO use, increasing resistance in the venous line and reducing blood flow. This can lead to inadequate oxygenation and serious complications for patients on life support.

Who’s affected

Patients using ECMO life support systems with the Better-Bladder BB14 model are affected. Healthcare providers using this specific circuit component are at highest risk.

How to tell if you have this one

Check for model BB14 on the device. Affected units have lot number 5290-201001 and UDI (Unique Device Identification) code (01)00851997007004(10)5290-201001(17)20231021(11)20201021.

  • Brand
    Circulatory Technology
  • Product
    The Better-Bladder (BB), part of extracorporeal membrane oxygenation (ECMO) cardiopulmonary bypass circuits. Model: BB14
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Immediately

    The Better-Bladder BB14 may collapse during ECMO use, causing reduced blood flow. Discontinue use immediately.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 11 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: nationwideOHPennsylvania: named in the noticePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: named in the noticeARTennessee: nationwideTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “US Nationwide distribution in the states of AL, AR, CA, DC, FL, GA, IN, MO, NC, PA, SC, TX.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arkansas, California, District of Columbia, Florida, Georgia, Indiana, Missouri, North Carolina, Pennsylvania, South Carolina, Texas.

Recall timeline

FDA published this recall 57 days after the firm started it.

1. Firm started the recall: Apr 27, 202112. FDA classified it Class II: Jun 15, 202123. Published in FDA’s Enforcement Report: Jun 23, 202132021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1862-2021 (April 27, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1862-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA